Search research articles
Contact Us
Filters
Showing results (181-190 of 471) with videos related to
Page
of 48
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2008
The cost-effective use of 18F-FDG PET in the presurgical evaluation of medically refractory focal epilepsy
Terence J O'Brien, Ken Miles, Robert Ware, et al.
The Oncologist
|
February 22, 2017
The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review
Michael Michael, Rocio Garcia-Carbonero, Matthias M Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2006
Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02
Danny Rischin, Rodney J Hicks, Richard Fisher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 15, 2012
18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data
Thomas W Barber, Cuong P Duong, Trevor Leong, et al.
EJNMMI Research
|
February 10, 2019
Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CT
David A Pattison, Lisa L MacFarlane, Jason Callahan, et al.
Neurobiology of Disease
|
May 26, 2009
Lamina-specific changes in hippocampal GABA(A)/cBZR and mossy fibre sprouting during and following amygdala kindling in the rat
David S H Liu, Terence J O'Brien, David A Williams, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 11, 2022
A 2022 International Survey on the Status of Prostate Cancer Theranostics
Thomas Beyer, Johannes Czernin, Lutz Freudenberg, et al.
Frontiers in Oncology
|
May 3, 2021
Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell Carcinoma
Annette M Lim, Karda Cavanagh, Rodney J Hicks, et al.
Molecular Cancer Therapeutics
|
September 20, 2005
Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging
Benjamin Solomon, David Binns, Peter Roselt, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 9, 2013
High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma
Raghava Kashyap, Eddie Lau, Anupkumar George, et al.
Page
of 48
Search research articles
Search
Showing results (181-190 of 471) with videos related to
Sort By:
Page
of 48
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2008
The cost-effective use of 18F-FDG PET in the presurgical evaluation of medically refractory focal epilepsy
Terence J O'Brien, Ken Miles, Robert Ware, et al.
The Oncologist
|
February 22, 2017
The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review
Michael Michael, Rocio Garcia-Carbonero, Matthias M Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2006
Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02
Danny Rischin, Rodney J Hicks, Richard Fisher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 15, 2012
18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data
Thomas W Barber, Cuong P Duong, Trevor Leong, et al.
EJNMMI Research
|
February 10, 2019
Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CT
David A Pattison, Lisa L MacFarlane, Jason Callahan, et al.
Neurobiology of Disease
|
May 26, 2009
Lamina-specific changes in hippocampal GABA(A)/cBZR and mossy fibre sprouting during and following amygdala kindling in the rat
David S H Liu, Terence J O'Brien, David A Williams, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 11, 2022
A 2022 International Survey on the Status of Prostate Cancer Theranostics
Thomas Beyer, Johannes Czernin, Lutz Freudenberg, et al.
Frontiers in Oncology
|
May 3, 2021
Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell Carcinoma
Annette M Lim, Karda Cavanagh, Rodney J Hicks, et al.
Molecular Cancer Therapeutics
|
September 20, 2005
Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging
Benjamin Solomon, David Binns, Peter Roselt, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 9, 2013
High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma
Raghava Kashyap, Eddie Lau, Anupkumar George, et al.
Page
of 48